Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer

被引:30
作者
Benachenhou, N
Guiral, S
Gorska-Flipot, I
Labuda, D
Sinnett, D
机构
[1] St Justine Hosp, Res Ctr, Ctr Cancerol Charles Bruneau, Div Hematooncol, Montreal, PQ H3T 1C5, Canada
[2] Montreal Hotel Dieu Hosp, Div Pathol, Montreal, PQ, Canada
[3] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada
基金
英国医学研究理事会;
关键词
mismatch-repair; hMLH1; hMSH3; loss of heterozygosity; breast cancer;
D O I
10.1038/sj.bjc.6690162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To study the involvement of DNA mismatch-repair genes in sporadic breast cancer, matched normal and tumoral DNA samples of 22 patients were analysed for genetic instability and loss of heterozygosity (LOH) with 42 microsatellites at or linked to hMLH1 (3p21), hMSH2 (2p16), hMSH3 (5q11-q13), hMSH6 (2p16), hPMS1 (2q32) and hPMS2 (7q22) loci. Chromosomal regions 3q21 and 5q11-q13 were found hemizygously deleted in 46% and 23% of patients respectively. Half of the patients deleted at hMLH1 were also deleted at hMSH3. The shortest regions of overlapping (SRO) deletions were delimited by markers D3S1298 and D3S1266 at 3p21 and by D5S647 and D5S418 at 5q11-q13. Currently, the genes hMLH1 (3p21) and hMSH3 (5q11-q13) are the only known candidates located within these regions. The consequence of these allelic losses is still unclear because none of the breast cancers examined displayed microsatellite instability, a hallmark of mismatch-repair defect during replication error correction. We suggest that hMLH1 and hMSH3 could be involved in breast tumorigenesis through cellular functions other than replication error correction.
引用
收藏
页码:1012 / 1017
页数:6
相关论文
共 67 条
[1]  
Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO
[2]  
2-J
[3]  
ASHTONRICKARDT PG, 1991, ONCOGENE, V6, P1881
[4]   Allelic loss in childhood acute lymphoblastic leukemia [J].
Baccichet, A ;
Qualman, SK ;
Sinnett, D .
LEUKEMIA RESEARCH, 1997, 21 (09) :817-823
[5]   Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5'''-P-1,P-3-triphosphate hydrolase [J].
Barnes, LD ;
Garrison, PN ;
Siprashvili, Z ;
Guranowski, A ;
Robinson, AK ;
Ingram, SW ;
Croce, CM ;
Ohta, M ;
Huebner, F .
BIOCHEMISTRY, 1996, 35 (36) :11529-11535
[6]  
Benachenhou N, 1998, INT J CANCER, V77, P173, DOI 10.1002/(SICI)1097-0215(19980717)77:2<173::AID-IJC1>3.0.CO
[7]  
2-N
[8]  
BENACHENHOU N, 1998, IN PRESS CARCINOGENE
[9]   GENETIC ALTERATIONS IN BREAST-CANCER [J].
BIECHE, I ;
LIDEREAU, R .
GENES CHROMOSOMES & CANCER, 1995, 14 (04) :227-251
[10]   LOSS OF HETEROZYGOSITY INVOLVING THE APC AND MCC GENETIC-LOCI OCCURS IN THE MAJORITY OF HUMAN ESOPHAGEAL CANCERS [J].
BOYNTON, RF ;
BLOUNT, PL ;
YIN, J ;
BROWN, VL ;
HUANG, Y ;
TONG, Y ;
MCDANIEL, T ;
NEWKIRK, C ;
RESAU, JH ;
RASKIND, WH ;
HAGGITT, RC ;
REID, BJ ;
MELTZER, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3385-3388